/Companies

NeuroOne

Eden Prairie, US · Founded 2016 · Delaware corporation · 1 known investors

Find your way into NeuroOne

882 people in our graph share verified history with the NeuroOne team — schools, employers, funds. One of them is your warm intro.

Hanson S. Gifford, IIIunlockedknows Steve Mertens · together at Nuvaira (overlapped)
×2knows the team · via Cardiovascular Systems, Inc.
knows the team · via CR Bard
knows the team · via St. Jude Medical
knows the team · via Universidad Nacional de Colombia
×4knows the team · via Neuro Event Labs Oy

NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.

Founders & leadership

DRDave Rosa
Dave RosaPresident & Chief Executive OfficerHe has three decades of experience in the medical device industry, including senior roles at C.R. Bard, Boston Scientific, and St. Jude Medical in marketing, product development, and business development; he holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.
DWDavid Wambecke
David WambeckeChief Business Officer
CVChris Volker
Chris VolkerChief Financial OfficerChris Volker held general management and corporate development roles in medtech, healthcare, and technology companies, with experience in mergers and acquisitions, private equity investments, and strategic partnerships. He has served on boards and in functional leadership across quality, marketing, reimbursement, and human resources.
SMSteve Mertens
Steve MertensChief Technology OfficerSteve Mertens is Chief Technology Officer at NeuroOne, which develops neurotechnology combining medical devices and artificial intelligence. He has experience in research, product development, manufacturing, and commercialization across startup and large-company environments.
EJEmily Johns
Emily JohnsChief Administrative Officer & General Counsel
CDCamilo Diaz-Botia
Camilo Diaz-BotiaVice President of EngineeringCamilo Diaz-Botia brings seven years of neural engineering experience focused on implantable medical devices, with expertise in microfabrication design and integrated systems development. He is Vice President of Engineering at NeuroOne, a neurotechnology company combining medical devices and artificial intelligence.
MCMark Christianson
Mark ChristiansonCo-Founder, VP of Business DevelopmentServes as VP of Business Development at the company he co-founded in 2016. His earlier career includes North American technical sales management at Cortec Corporation, business development at Robert Half Technology, and a regional medical device sales role at PMT Corporation.
WF
Wade FredricksonNamed on SEC filing
SK
Suraj KaliaNamed on SEC filing
JMJeff Mathiesen
Jeff MathiesenNamed on SEC filing
PBPaul Buckman
Paul BuckmanNamed on SEC filing
TB
Thomas BachinskiNamed on SEC filing

Investors · 1

FundRxreportedPalo Alto

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.5M disclosed across 1 round · 2016

▶$1.5MraisedJun 2017 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark ChristiansonExecutive Officer
  • Wade FredricksonExecutive Officer
  • Suraj KaliaDirector
  • Jeff MathiesenDirector
  • Paul BuckmanDirector
  • Thomas BachinskiExecutive Officer
  • David A RosaExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$1.5M
Minimum investment
$50K
Sales commissions
$120K
Placement agents
Corinthian Partners, L.L.C.
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Companies competing with NeuroOne for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does NeuroOne do?
NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.
Who are NeuroOne's investors?
NeuroOne's investors include FundRx.
How much funding has NeuroOne raised?
NeuroOne has disclosed $1.5M raised across 1 round.
Where is NeuroOne headquartered?
NeuroOne is headquartered in Eden Prairie, US.